PTGX - CIK 0001377121
Protagonist Therapeutics, Inc trades as PTGX and has a market capitalization of $6.80 B, making it the #1171 largest US-listed company by market value. This page tracks Protagonist Therapeutics, Inc through 668 SEC filings, with financial statements and metrics updated as new reports are filed.
| Filing | Type | Filed |
|---|---|---|
| Insider trade (amended) | 4/A | 2026-05-14 |
| Insider sale notice | 144 | 2026-05-12 |
| Insider trade | 4 | 2026-05-12 |
| Insider trade | 4 | 2026-05-11 |
| Insider sale notice | 144 | 2026-05-08 |
| Insider sale notice | 144 | 2026-05-07 |
| Insider sale notice | 144 | 2026-05-07 |
| Quarterly report | 10-Q | 2026-05-05 |
The largest companies sharing Protagonist Therapeutics, Inc's SEC industry classification (pharmaceutical preparations).
Protagonist Therapeutics, Inc (PTGX) has a market capitalization of $6.80 B as of 2026-06-10, ranking #1171 among US-listed companies.
In its latest fiscal year Protagonist Therapeutics, Inc reported a net loss of $130.15M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.